Jefferies Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jefferies Financial Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3,315	Closed	-$362K	–	1698
2026 Q2	$362K	Sell	3,315 -24,706	-88%	-$2.56M	﹤0.01%	1325
2026 Q1	$2.91M	Buy	28,021 +24,929	+806%	+$2.66M	0.02%	489
2025 Q4	$319K	Sell	3,092 -796	-20%	-$77.4K	﹤0.01%	1482
2025 Q3	$351K	Buy	3,888 +626	+19%	+$54.8K	﹤0.01%	1170
2025 Q2	$287K	Buy	+3,262	New	+$283K	﹤0.01%	1044
2024 Q4	–	Sell	-3,340	Closed	-$317K	–	1787
2024 Q3	$317K	Buy	3,340 +388	+13%	+$36.8K	﹤0.01%	1102
2024 Q2	$270K	Buy	+2,952	New	+$264K	﹤0.01%	1140

Other funds holding PPH

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

J. Safra Asset Management New York $2.3B AUM 21.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.59B AUM 27.25% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $548M AUM 16.52% 1-Year Est. Return

Miller Investment Management West Conshohocken, Pennsylvania $1.13B AUM 13.3% 1-Year Est. Return

Jefferies Financial Group's PPH Position: Q3 2026 in Review

Jefferies Financial Group sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2026, closing a stake of 3,315 shares — an estimated $362K sold.

Jefferies Financial Group first reported a position in PPH in Q2 2024 and held it in 7 quarters. The position peaked at $2.91M in Q1 2026. 124 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

Jefferies Financial Group reported no remaining VanEck Pharmaceutical ETF position as of Q3 2026 after selling out during the quarter.
Jefferies Financial Group sold 3,315 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $362K.
Jefferies Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and held it in 7 quarters.
Jefferies Financial Group's VanEck Pharmaceutical ETF position peaked at $2.91M in Q1 2026.
124 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.